PLoS Biology Mar 3, 2026 Developing monoclonal antibody therapies for measles could lead to adverse pathogen evolution
PharmaVoice Mar 3, 2026 J&J’s blockbuster Spravato is setting the stage for managing psychedelics’ risks
FierceBiotech Mar 3, 2026 AI musculoskeletal imaging medtechs Medimaps and Radiobotics pen merger deal
10x Genomics Blog Mar 3, 2026 10x Genomics, Inc. (TXG) Stock Analysis: A Closer Look at the Healthcare Innovator’s Growth Potential and Analyst Ratings - DirectorsTalk Interviews
Agilent Mar 3, 2026 Morgan Stanley Lowers Price Target on Agilent Technologies to $160 From $180, Keeps Overweight Rating - marketscreener.com
Agilent Mar 3, 2026 Champlain Investment Partners LLC Has $114.97 Million Stock Holdings in Agilent Technologies, Inc. $A - MarketBeat
Waters Mar 3, 2026 Champlain Investment Partners LLC Sells 94,439 Shares of Waters Corporation $WAT - MarketBeat
Roche Media Mar 3, 2026 Roche: Sustainable Operations, Supply Chains & AI in Health - Sustainability Magazine
FierceBiotech Mar 3, 2026 GLP-1s support heart attack recovery in rodents by relaxing tight blood vessels
Illumina Mar 3, 2026 Is Illumina’s (ILMN) TruPath Rare Disease Push Reframing Its Clinical Sequencing Investment Narrative? - simplywall.st
Lonza News Mar 3, 2026 Lonza Group AG: Quiet Rally In Swiss Biotech That U.S. Investors Are Missing - AD HOC NEWS
Illumina Mar 3, 2026 Cardiogenetic testing at scale: the TruGenome Cardiovascular Disease Test and CardioSeq Clinical Trial - Illumina
Agilent Mar 3, 2026 Agilent's Stock Plummets 2.64% as Trading Volume Dips to $0.41B, Ranking 322 in Daily Trading Activity Amid Earnings Miss and Post-Earnings Rally - Bitget
FierceBiotech Mar 3, 2026 HHS bans Claude AI tool as Trump seeks full government blacklisting of Anthropic
eLife Mar 3, 2026 Sperm motility in mice with oligo-astheno-teratozoospermia restored by in vivo injection and electroporation of naked mRNA